ABVX — Abivax S.A.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1956827 · France
Last close
$91.06
Market Cap
$7.95B
52W High
$148.83
52W Low
$69.81
ADV30
1,180,503
Next earnings
2026-09-21

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -84,110,000 -117,433,000 462,209,000 387,992,000 95,942,000
Mar 2026 0 — -56,229,000 -48,468,000 547,142,000 477,423,000 117,548,000
Dec 2025 0 — -71,648,000 -81,960,000 584,341,000 516,685,000 129,136,000
Sep 2025 0 — -80,712,000 -153,358,000 652,052,000 589,703,000 140,814,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-178,371,000
Investing CF
$-8,780,000
Financing CF
$555,218,000
CapEx
$-204,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-4.30
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-764,311,000
Inventory
—
Receivables
$10,809,000
ST Investments
$14,128,000
EBIT TTM
$-300,576,000
Pretax Income TTM
$-326,124,000
Interest Exp TTM
$25,548,000
Analysts
11

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,920,000
EBITDA
$-254,004,000
Free Cash Flow
$-114,471,872
Enterprise Value
$8,949,765,120
Total Cash
$491,552,000
Total Debt
$34,211,000
Shares Out
87,253,797
Trailing EPS
$-5.36
Book Value
$6.29
ROE
-157.1%
ROA
-44.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -246,056,000 -336,102,000 584,341,000 129,136,000 455,205,000 -161,129,000
Dec 2024 0 -172,984,000 -176,242,000 205,228,000 164,644,000 40,584,000 -154,072,000
Dec 2023 0 -127,377,000 -147,740,000 327,062,000 131,052,000 196,010,000 -97,130,000
Dec 2022 0 -51,205,000 -60,740,000 75,544,000 68,355,000 7,189,000 -53,936,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-3.34

Max Pain — expiry 2026-10-02

max pain strike: $105.00 · spot: $91.06 · call oi: 4,888 · put oi: 5,161
Expected Move to 2026-10-02: ±$5.97 (6.56%) — implied range $85.09 – $97.03 · ATM straddle on $92.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PRAX Praxis Precision Medicines, Inc. $7.84B $280.78 —
SYRE Spyre Therapeutics, Inc. $7.56B $85.69 —
IONS IONIS PHARMACEUTICALS INC $7.40B $44.50 —
TGTX TG THERAPEUTICS, INC. $8.79B $57.43 —
CYTK CYTOKINETICS INC $8.99B $64.66 —

News headlines (Yahoo Finance, 1h cache)

ABIVAX (ABVX) Uses More Cash. Can its Funding Cover a Potential Launch?
2026-09-26 04:03 · Yahoo
Abivax Presents Business Updates and First Half 2026 Financial Results
2026-09-21 20:05 · Yahoo
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why
2026-09-08 16:00 · Yahoo
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight
2026-09-07 17:00 · Yahoo
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | Delve
2026-07-30 14:31 · Yahoo
PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants
2026-07-29 07:00 · Yahoo
ABIVAX Société Anonyme (ENXTPA:ABVX) Just Gave Investors Something To Think About
2026-09-27 09:09 · Yahoo
ABIVAX Société Anonyme (ENXTPA:ABVX) Appoints New Chief Medical And Technical Officers
2026-09-26 19:08 · Yahoo
4 Biotech Stocks to Watch as Potential Takeover Targets
2026-09-18 16:31 · Yahoo
Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Ca
2026-08-04 07:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.